Skip to content

Monday, March 31, 2025

Latest:

Gasdermin D emerges as a potential therapeutic target for atrial fibrillation
Healthy Habits: Dr. Sun In Kim-Vences is an ultramarathoner
Endometriosis and the lesser-known thoracic endometriosis syndrome
Postpartum female preference for cooler temperatures linked to brain changes
Baylor Genetics marks 10th anniversary: A look back at a decade of innovation in genetic testing

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

gasdermin D

A model valentine-style heart sitting next to a stethoscope.

Gasdermin D emerges as a potential therapeutic target for atrial fibrillation

March 27, 2025 atria, atrial fibrillation, Dementia, gasdermin D, heart cells, heart failure, mitochondria, reactive oxygen species, Research, Stroke

This study reveals that gasdermin D plays a novel role in the development of atrial fibrillation through multifaceted mechanisms.

From the Labs: Image of the Month

From the Labs: Zika virus builds underground tunnels

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951